Patents by Inventor John R. Asplin

John R. Asplin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Clinical laboratory-based disease management program, with automated patient-specific treatment advice
    Patent number: 11901054
    Abstract: A method is provided, the method including receiving a test result data, wherein said test result data represents a result of a test on a physical specimen, associating said test result data with a standard-of-care data, wherein said standard-of-care data represents a recommended course of action for the condition represented by the test result data, and transforming said specimen data and said standard-of-care data into a human-readable form. A system including a processor is provided, a software adapted to be executed on said processor, said software comprising instructions for receiving a test result data, wherein said test result data represents a result of a test on a physical specimen, associating said test result data with a standard-of-care data, wherein said standard-of-care data represents a recommended course of action for the condition represented by the test result data, and transforming said specimen data and said standard-of-care data into a human-readable form.
    Type: Grant
    Filed: November 2, 2021
    Date of Patent: February 13, 2024
    Assignee: Laboratory Corporation of America Holdings
    Inventors: Fredric L. Coe, Brian J. Coe, John R. Asplin, Enno de Vries, Elaine Worcester
  • Clinical Laboratory-Based Disease Management Program, With Automated Patient-Specific Treatment Advice
    Publication number: 20220230719
    Abstract: A method is provided, the method including receiving a test result data, wherein said test result data represents a result of a test on a physical specimen, associating said test result data with a standard-of-care data, wherein said standard-of-care data represents a recommended course of action for the condition represented by the test result data, and transforming said specimen data and said standard-of-care data into a human-readable form. A system including a processor is provided, a software adapted to be executed on said processor, said software comprising instructions for receiving a test result data, wherein said test result data represents a result of a test on a physical specimen, associating said test result data with a standard-of-care data, wherein said standard-of-care data represents a recommended course of action for the condition represented by the test result data, and transforming said specimen data and said standard-of-care data into a human-readable form.
    Type: Application
    Filed: November 2, 2021
    Publication date: July 21, 2022
    Applicant: Laboratory Corporation of America Holdings
    Inventors: Fredric L. Coe, Brian J. Coe, John R. Asplin, Enno de Vries, Elaine Worcester
  • Clinical laboratory-based disease management program, with automated patient-specific treatment advice
    Patent number: 11195603
    Abstract: A method is provided, the method including receiving a test result data, wherein said test result data represents a result of a test on a physical specimen, associating said test result data with a standard-of-care data, wherein said standard-of-care data represents a recommended course of action for the condition represented by the test result data, and transforming said specimen data and said standard-of-care data into a human-readable form. A system including a processor is provided, a software adapted to be executed on said processor, said software comprising instructions for receiving a test result data, wherein said test result data represents a result of a test on a physical specimen, associating said test result data with a standard-of-care data, wherein said standard-of-care data represents a recommended course of action for the condition represented by the test result data, and transforming said specimen data and said standard-of-care data into a human-readable form.
    Type: Grant
    Filed: May 6, 2019
    Date of Patent: December 7, 2021
    Assignee: Laboratory Corporation of America Holdings
    Inventors: Fredric L. Coe, Brian J. Coe, John R. Asplin, Enno de Vries, Elaine Worcester
  • Clinical Laboratory-Based Disease Management Program, With Automated Patient-Specific Treatment Advice
    Publication number: 20200043584
    Abstract: A method is provided, the method including receiving a test result data, wherein said test result data represents a result of a test on a physical specimen, associating said test result data with a standard-of-care data, wherein said standard-of-care data represents a recommended course of action for the condition represented by the test result data, and transforming said specimen data and said standard-of-care data into a human-readable form. A system including a processor is provided, a software adapted to be executed on said processor, said software comprising instructions for receiving a test result data, wherein said test result data represents a result of a test on a physical specimen, associating said test result data with a standard-of-care data, wherein said standard-of-care data represents a recommended course of action for the condition represented by the test result data, and transforming said specimen data and said standard-of-care data into a human-readable form.
    Type: Application
    Filed: May 6, 2019
    Publication date: February 6, 2020
    Applicant: Laboratory Corporation of America Holdings
    Inventors: Fredric L. Coe, Brian J. Coe, John R. Asplin, Enno de Vries, Elaine Worcester
  • Clinical laboratory-based disease management program, with automated patient-specific treatment advice
    Patent number: 10290369
    Abstract: A method is provided, the method including receiving a test result data, wherein said test result data represents a result of a test on a physical specimen, associating said test result data with a standard-of-care data, wherein said standard-of-care data represents a recommended course of action for the condition represented by the test result data, and transforming said specimen data and said standard-of-care data into a human-readable form. A system including a processor is provided, a software adapted to be executed on said processor, said software comprising instructions for receiving a test result data, wherein said test result data represents a result of a test on a physical specimen, associating said test result data with a standard-of-care data, wherein said standard-of-care data represents a recommended course of action for the condition represented by the test result data, and transforming said specimen data and said standard-of-care data into a human-readable form.
    Type: Grant
    Filed: January 31, 2013
    Date of Patent: May 14, 2019
    Assignee: Laboratory Corporation of America Holdings
    Inventors: Fredric L. Coe, Brian J. Coe, John R. Asplin, Enno de Vries, Elaine Worcester
  • Clinical Laboratory-Based Disease Management Program, With Automated Patient-Specific Treatment Advice
    Publication number: 20100030574
    Abstract: A method is provided, the method including receiving a test result data, wherein said test result data represents a result of a test on a physical specimen, associating said test result data with a standard-of-care data, wherein said standard-of-care data represents a recommended course of action for the condition represented by the test result data, and transforming said specimen data and said standard-of-care data into a human-readable form. A system is provided, the system including a processor, a software adapted to be executed on said processor, said software comprising instructions for receiving a test result data, wherein said test result data represents a result of a test on a physical specimen, associating said test result data with a standard-of-care data, wherein said standard-of-care data represents a recommended course of action for the condition represented by the test result data, and transforming said specimen data and said standard-of-care data into a human-readable form.
    Type: Application
    Filed: August 4, 2009
    Publication date: February 4, 2010
    Inventors: Fredric L. Coe, Brian J. Coe, John R. Asplin, Enno de Vries, Elaine Worcester
  • Urine cystine quantitation and supersaturation assay
    Patent number: 6991937
    Abstract: A method for measuring cystine supersaturation of a patient urine sample as an indicator of the patient's risk for cystine stone formation has been found. A method for collecting a patient urine sample for assessment of cystine concentration and cystine supersaturation has also been found.
    Type: Grant
    Filed: October 26, 2001
    Date of Patent: January 31, 2006
    Assignee: Litholink Corporation
    Inventors: John R. Asplin, Fredric L. Coe
  • Urine cystine quantitation and supersaturation assay
    Publication number: 20030087449
    Abstract: A method for measuring cystine supersaturation of a patient urine sample as an indicator of the patient's risk for cystine stone formation has been found. A method for collecting a patient urine sample for assessment of cystine concentration and cystine supersaturation has also been found.
    Type: Application
    Filed: October 26, 2001
    Publication date: May 8, 2003
    Inventors: John R. Asplin, Fredric L. Coe